Russian Journal of Immunology · Oct 31, 2026

In vitro effects of synthetic immunotropic hexapeptides on CD63-CD16+CD62L+CD11b+ and CD63+CD16+CD62L+CD11b+ neutrophilic granulocytes in elderly and senile patients with chronic obstructive pulmonary disease

By Poezzhaev EA, Ковалева СВ, Teterin YV

Neutrophilic granulocyte (NG) undergoes significant functional changes with aging, leading to both disturbed effector mechanisms of anti-infective immunity, and development of age-associated diseases and geriatric syndromes. Therefore, the novel approaches using immunotropic substances are relevant in experimental remodeling of NG dysfunctions associated with aging. Our objective was to study the effect of two synthetic hexapeptides (lysyl-histidyl-glycyl-lysyl-histidyl-glycine and arginyl-a-aspartyl-lysyl-valyl-tyrosyl-arginine) on the quantitative and phenotypic characteristics of NG subsets CD63-CD16+CD62L+CD11b+ and CD63+CD16+CD62L+CD11b+ in elderly and senile patients with chronic obstructive pulmonary disease (COPD). By means of flow cytometry techniques (Beckman Coulter DxFLEX, USA, China), we determined the number of circulating peripheral blood NG expressing CD63, CD16, CD62L, and CD11b, as well as the expression density of these receptors before and after incubation with the mentioned peptides. We tested these substances with NGs from peripheral blood of 55 elderly and senile patients with COPD, and 20 conditionally healthy elderly and senile individuals. It was revealed that peripheral blood of conditionally healthy elderly and senile individuals, contains four NG subsets with different expression densities of CD63, CD16, CD62L, and CD11b: CD63-CD16brightCD62LbrightCD11bmid, CD63-CD16brightCD62LdimCD11bmid, CD63+CD16brightCD62LbrightCD11bmid, and CD63+CD16brightCD62LdimCD11bmid. In elderly and senile patients with COPD, these subsets differ from those in healthy controls in CD11b expression density:CD63-CD16brightCD62LbrightCD11bbright, CD63-CD16brightCD62LdimCD11bbright, CD63+CD16brightCD62LbrightCD11bbright, CD63+CD16brightCD62LdimCD11bbright. Moreover, patients with COPD exhibit an increased content of NG subset with activation phenotype CD63+CD16brightCD62LbrightCD11bbright, which exhibits cytotoxic activity; as well as a subpopulation with cytotoxic and immunosuppressive activity with CD63+CD16brightCD62LdimCD11bbright phenotype, as compared to healthy elderly controls. Incubation with lysyl-histidyl-glycyl-lysyl-histidyl-glycine leads to an increase in the NG subset CD63-CD16brightCD62LbrightCD11bbright, and a decrease in the NG subset CD63+CD16brightCD62LbrightCD11bbright. Lysyl-histidyl-glycyl-lysyl-histidyl-glycine has a modulating effect, reducing the density of CD11b expression on the following NG subsets: CD63-CD16brightCD62LbrightCD11bbright, CD63-CD16brightCD62LdimCD11bbright, CD63+CD16brightCD62LdimCD11bbright, and increasing density of CD16 expression on the NG subsets CD63-CD16brightCD62LbrightCD11bbright. After incubation with arginyl-a-aspartyl-lysyl-valyl-tyrosyl-arginine, an increase in the neutrophil granulocyte subset CD63-CD16brightCD62LbrightCD11bbright was observed, while the CD63+CD16brightCD62LbrightCD11bbright and CD63+CD16brightCD62LdimCD11bbright neutrophil subsets were reduced. The obtained data indicate a positive immunological effect of the studied immunotropic substances in vitro, which can serve as a basis for further clinical trials of medicinal products based on them in immunocompromised elderly and senile patients with COPD.

doi.org/10.46235/1028-7221-17493-iveOpen accessInterventions

AgingResearch.News